Personal profile
Education/Academic qualification
Recognised by Advance HE as a Senior Fellow against Descriptor 3 of the UKPSF
18 Nov 2024 → …
Holder of a PGCE in higher education, secondary education, further education, life long learning or any other equivalent UK qualification
Recognised by Advance HE as a Fellow against Descriptor 2 of the UKPSF
Doctorate
Fingerprint
Dive into the research topics where Terry Gaymes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
A Phase I trial of talazoparib in patients with advanced hematologic malignancies
Gopal, A. K., Popat, R., Mattison, R. J., Menne, T., Bloor, A., Gaymes, T., Khwaja, A., Juckett, M., Chen, Y., Cotter, M. J. & Mufti, G. J., 2021, In: Arztliche Praxis Neurologie Psychiatrie. 10, 3, IJH35.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Downloads (Pure) -
FLT3 and JAK2 mutations in acute myeloid leukemia promote interchromosomal homologous recombination and the potential for copy neutral loss of heterozygosity
Mohamedali, A., Gaymes, T. J., Eiliazadeh, A. L., Darling, D. & Mufti, G. J., Apr 2017, In: Cancer Research. 77, 7, p. 1697-1708Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)
Mohamedali, A. M., Gaken, J., Ahmed, M., Malik, F., Smith, A. E., Best, S., Mian, S., Gaymes, T., Ireland, R., Kulasekararaj, A. G. & Mufti, G. J., 30 Sept 2015, In: Leukemia. 29, 9, p. 1928-1938Research output: Contribution to journal › Article › peer-review
-
PARP inhibitor sensitivity in high risk MDS and acute myeloid leukaemia is associated with microsatellite instability dependent frameshift mutations in DNA repair genes
Gaymes, T. J., Mohamedali, A. M., Patterson, M., Matto, N., Smith, A., Kulasekaraj, A., Chelliah, R., Curtin, N., Farzaneh, F., Shall, S. & Mufti, G. J., 1 Sept 2013, In: Haematologica. 98, 9, p. 1397-1406Research output: Contribution to journal › Article › peer-review
-
The use of PARP inhibitors in cancer therapy: use as adjuvant with chemotherapy or radiotherapy ; use as a single agent in susceptible patients ; techniques used to identify susceptible patients
Shall, S., Gaymes, T., Farzaneh, F., Curtin, N. & Mufti, G. J., 2011, Poly(ADP-Ribose) Polymerase: Methods and Protocols. Tulin, A. V. (ed.). New York, NY: Springer, p. 239-266 (Methods in Molecular Biology).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review